Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
2
×
clinical trials
deals
fda
2
×
gene therapy
johnson & johnson
life sciences
medicaid
2
×
national blog main
national top stories
new york blog main
new york top stories
novartis
2
×
spinal muscular atrophy
abeona therapeutics
achaogen
achromatopsia
affordable care act
alnylam pharmaceuticals
alzheimer's
amgen
astrazeneca
beta-thalassemia
bill cassidy
biosimilar
bluebird bio
boulder/denver blog main
boulder/denver top stories
brexanolone
celiac disease
chris collins
coherus biosciences
cydan development
detroit blog main
detroit top stories
dna
egfr
eli lilly
foamix pharmaceuticals
What
age
alzheimer’s
bigger
biggest
bio
come
congress
deal
democrats
divided
elections
emerging
fallout
gave
gene
j
johnson
losses
meiragtx
midterm
morning
panel
past
plenty
political
postpartum
roundup
search
signal
signals
stake
terms
therapy
took
week’s
wins
years
Language
Current search:
medicaid
×
novartis
×
fda
×
" boston top stories "
×
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel